Literature DB >> 9544144

Primary lymphoma of the thyroid.

J A Singer1.   

Abstract

Primary lymphoma is an uncommon malignancy of the thyroid, comprising between 0.6 and 5 per cent of thyroid cancers in most series. This report is presented because of a 10 per cent (6 of 60) incidence of this cancer at one institution. A short history of a rapidly enlarging neck mass often associated with dyspnea, difficulty swallowing, or voice change is the hallmark presentation of thyroid lymphoma. The majority of patients are women with a mean age in the 6th decade. Although fine-needle aspiration has become the procedure of choice for the diagnosis of a thyroid nodule, it has yielded mixed results with the presence of lymphoma. The majority of thyroid lymphomas are diffuse, large cell lesions of B-cell origin. Controversy remains as to the role of surgery in thyroid lymphomas. Within the improvement in results with the use of radiotherapy and chemotherapy alone or in combination, some authors have advocated relegating surgery to the role of diagnosis only. This can be accomplished by fine-needle aspiration, core biopsy, or open biopsy. Others have favored a more aggressive surgical approach, showing that the amount of residual disease after debulking procedures was directly correlated with local and distant recurrences. A lack of randomized prospective studies makes it difficult to resolve this issue. The rates of complications of surgery, including hypocalcemia and recurrent laryngeal nerve damage, are higher than for operations for other types of thyroid malignancy. Improved prognosis has been associated with the following factors: disease limited to the thyroid, the absence of dysphagia, primary mass less than 10 cm, tumors without necrosis, and tumors consisting of plasmacytomas.

Entities:  

Mesh:

Year:  1998        PMID: 9544144

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  8 in total

Review 1.  T-cell Lymphoma of Thyroid Gland with Lennert Type of Morphology: A Case Report and Review of the Literature.

Authors:  Prabhashankar Mishra; Devmalya Banerjee; Sumeet Gujral
Journal:  Head Neck Pathol       Date:  2016-03-16

Review 2.  An evidence-based approach to the treatment of thyroid lymphoma.

Authors:  Lloyd A Mack; Janice L Pasieka
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

3.  Primary T-cell lymphoma of the thyroid associated with Hashimoto's thyroiditis, histologically mimicking MALT-lymphoma.

Authors:  Na Rae Kim; Young-Hyeh Ko; Young-Don Lee
Journal:  J Korean Med Sci       Date:  2010-02-19       Impact factor: 2.153

4.  Problems of primary T-cell lymphoma of the thyroid gland--a case report.

Authors:  Junkichi Yokoyama; Shin Ito; Shinichi Ohba; Mitsuhisa Fujimaki; Eriko Sato; Norio Komatsu; Katsuhisa Ikeda; Makoto Hanaguri
Journal:  World J Surg Oncol       Date:  2012-04-19       Impact factor: 2.754

5.  Fine needle aspiration cytology of primary thyroid lymphoma: a report of ten cases.

Authors:  Nalini Gupta; Raje Nijhawan; Radhika Srinivasan; Arvind Rajwanshi; Pinaki Dutta; Anil Bhansaliy; S C Sharma
Journal:  Cytojournal       Date:  2005-12-09       Impact factor: 2.091

6.  Diffuse large B cell lymphoma of thyroid as a masquerader of anaplastic carcinoma of thyroid, diagnosed by FNA: a case report.

Authors:  Yahya Daneshbod; Shapour Omidvari; Khosrow Daneshbod; Shahrzad Negahban; Mehdi Dehghani
Journal:  Cytojournal       Date:  2006-10-19       Impact factor: 2.091

7.  Survival and failure outcomes in primary thyroid lymphomas: a single centre experience of combined modality approach.

Authors:  Ritesh Kumar; Divya Khosla; Narendra Kumar; Sushmita Ghoshal; Anjan Bera; Ashim Das; Suresh Chander Sharma
Journal:  J Thyroid Res       Date:  2013-09-12

Review 8.  Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.

Authors:  Elena Vigliar; Alessia Caleo; Mario Vitale; Vincenzo Di Crescenzo; Alfredo Garzi; Pio Zeppa
Journal:  BMC Surg       Date:  2013-10-08       Impact factor: 2.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.